Clinical trial
Phase 2 Study of Fingolimod in Lung Cancers
NCT06424067
Study timeline
Study start (actual)2025-05-01Date precision: day
Registry last updated2026-03-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Small-cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Medical University of South Carolinalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06424067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.